Exact Mass: 696.590373

Exact Mass Matches: 696.590373

Found 44 metabolites which its exact mass value is equals to given mass value 696.590373, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

CE(22:6(4Z,7Z,10Z,13Z,16Z,19Z))

(2R,5S,15R)-2,15-Dimethyl-14-[(2R)-6-methylheptan-2-yl]tetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadec-7-en-5-yl (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoic acid

C49H76O2 (696.5844996)


Cholesteryl docosahexaenoic acid is a cholesteryl ester. A cholesteryl ester is an ester of cholesterol. Fatty acid esters of cholesterol constitute about two-thirds of the cholesterol in the plasma. Cholesterol is a sterol (a combination steroid and alcohol) and a lipid found in the cell membranes of all body tissues, and transported in the blood plasma of all animals. The accumulation of cholesterol esters in the arterial intima (the innermost layer of an artery, in direct contact with the flowing blood) is a characteristic feature of atherosclerosis. Atherosclerosis is a disease affecting arterial blood vessels. It is a chronic inflammatory response in the walls of arteries, in large part to the deposition of lipoproteins (plasma proteins that carry cholesterol and triglycerides). Depression has been found weakly related to serum cholesteryl ester arachidonic/docosahexaenoic fatty acid ratio. In healthy human receiving a diet rich in docosahexaenoic acid (DHA), it was incorporated into LDL cholesteryl esters; DHA does not appear to increase the susceptibility of LDL to oxidation. Lower levels of DHA were found in all plasma lipid fractions from infants fed formula compared with those in the human milk-fed infants, irrespective of the source of the formula supplement. (PMID: 16482070, 15262190, 15051839). Cholesteryl docosahexaenoic acid is a cholesteryl ester. A cholesteryl ester is an ester of cholesterol. Fatty acid esters of cholesterol constitute about two-thirds of the cholesterol in the plasma. Cholesterol is a sterol (a combination steroid and alcohol) and a lipid found in the cell membranes of all body tissues, and transported in the blood plasma of all animals. The accumulation of cholesterol esters in the arterial intima (the innermost layer of an artery, in direct contact with the flowing blood) is a characteristic feature of atherosclerosis. Atherosclerosis is a disease affecting arterial blood vessels. It is a chronic inflammatory response in the walls of arteries, in large part to the deposition of lipoproteins (plasma proteins that carry cholesterol and triglycerides).

   

22:6 Cholesteryl ester

2,15-dimethyl-14-(6-methylheptan-2-yl)tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-7-en-5-yl docosa-4,7,10,13,16,19-hexaenoate

C49H76O2 (696.5844996)


   

DG(21:0/18:1(12Z)-2OH(9,10)/0:0)

(2S)-2-{[(9S,10S,12Z)-9,10-dihydroxyoctadec-12-enoyl]oxy}-3-hydroxypropyl henicosanoic acid

C42H80O7 (696.590373)


DG(21:0/18:1(12Z)-2OH(9,10)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(21:0/18:1(12Z)-2OH(9,10)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(18:1(12Z)-2OH(9,10)/21:0/0:0)

(2S)-1-{[(9R,10R,12Z)-9,10-dihydroxyoctadec-12-enoyl]oxy}-3-hydroxypropan-2-yl henicosanoic acid

C42H80O7 (696.590373)


DG(18:1(12Z)-2OH(9,10)/21:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(18:1(12Z)-2OH(9,10)/21:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(21:0/0:0/18:1(12Z)-2OH(9,10))

(2R)-3-{[(9R,10R,12Z)-9,10-dihydroxyoctadec-12-enoyl]oxy}-2-hydroxypropyl henicosanoic acid

C42H80O7 (696.590373)


DG(21:0/0:0/18:1(12Z)-2OH(9,10)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(18:1(12Z)-2OH(9,10)/0:0/21:0)

(2S)-3-{[(9R,10R,12Z)-9,10-dihydroxyoctadec-12-enoyl]oxy}-2-hydroxypropyl henicosanoic acid

C42H80O7 (696.590373)


DG(18:1(12Z)-2OH(9,10)/0:0/21:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(a-21:0/18:1(12Z)-2OH(9,10)/0:0)

(2S)-2-{[(9S,10S,12Z)-9,10-dihydroxyoctadec-12-enoyl]oxy}-3-hydroxypropyl 18-methylicosanoic acid

C42H80O7 (696.590373)


DG(a-21:0/18:1(12Z)-2OH(9,10)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-21:0/18:1(12Z)-2OH(9,10)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(18:1(12Z)-2OH(9,10)/a-21:0/0:0)

(2S)-1-{[(9R,10R,12Z)-9,10-dihydroxyoctadec-12-enoyl]oxy}-3-hydroxypropan-2-yl 18-methylicosanoic acid

C42H80O7 (696.590373)


DG(18:1(12Z)-2OH(9,10)/a-21:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(18:1(12Z)-2OH(9,10)/a-21:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(a-21:0/0:0/18:1(12Z)-2OH(9,10))

(2R)-3-{[(9R,10R,12Z)-9,10-dihydroxyoctadec-12-enoyl]oxy}-2-hydroxypropyl 18-methylicosanoic acid

C42H80O7 (696.590373)


DG(a-21:0/0:0/18:1(12Z)-2OH(9,10)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(18:1(12Z)-2OH(9,10)/0:0/a-21:0)

(2S)-3-{[(9R,10R,12Z)-9,10-dihydroxyoctadec-12-enoyl]oxy}-2-hydroxypropyl 18-methylicosanoic acid

C42H80O7 (696.590373)


DG(18:1(12Z)-2OH(9,10)/0:0/a-21:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-21:0/18:1(12Z)-2OH(9,10)/0:0)

(2S)-2-{[(9S,10S,12Z)-9,10-dihydroxyoctadec-12-enoyl]oxy}-3-hydroxypropyl 19-methylicosanoic acid

C42H80O7 (696.590373)


DG(i-21:0/18:1(12Z)-2OH(9,10)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-21:0/18:1(12Z)-2OH(9,10)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(18:1(12Z)-2OH(9,10)/i-21:0/0:0)

(2S)-1-{[(9R,10R,12Z)-9,10-dihydroxyoctadec-12-enoyl]oxy}-3-hydroxypropan-2-yl 19-methylicosanoic acid

C42H80O7 (696.590373)


DG(18:1(12Z)-2OH(9,10)/i-21:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(18:1(12Z)-2OH(9,10)/i-21:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-21:0/0:0/18:1(12Z)-2OH(9,10))

(2R)-3-{[(9R,10R,12Z)-9,10-dihydroxyoctadec-12-enoyl]oxy}-2-hydroxypropyl 19-methylicosanoic acid

C42H80O7 (696.590373)


DG(i-21:0/0:0/18:1(12Z)-2OH(9,10)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(18:1(12Z)-2OH(9,10)/0:0/i-21:0)

(2S)-3-{[(9R,10R,12Z)-9,10-dihydroxyoctadec-12-enoyl]oxy}-2-hydroxypropyl 19-methylicosanoic acid

C42H80O7 (696.590373)


DG(18:1(12Z)-2OH(9,10)/0:0/i-21:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

CE(22:6)

cholest-5-en-3beta-yl (4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoate)

C49H76O2 (696.5844996)


A cholesterol ester in which the acyl group contains 22 carbons in total and 6 double bonds.

   

Cholesteryl docosahexaenoate

Cholest-5-en-3beta-yl (4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoic acid

C49H76O2 (696.5844996)


   

CE 22:6

cholest-5-en-3beta-yl (4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoate)

C49H76O2 (696.5844996)


   

tridodecyl 2-hydroxypropane-1,2,3-tricarboxylate

tridodecyl 2-hydroxypropane-1,2,3-tricarboxylate

C42H80O7 (696.590373)


   

TRIOCTYLDODECYL CITRATE

TRIOCTYLDODECYL CITRATE

C42H80O7 (696.590373)


   

1,4-Anhydro-3,5-di-O-stearoylhexitol

1,4-Anhydro-3,5-di-O-stearoylhexitol

C42H80O7 (696.590373)


   

22:6 Cholesteryl ester

22:6 Cholesteryl ester

C49H76O2 (696.5844996)


   

DG(a-21:0/18:1(12Z)-2OH(9,10)/0:0)

DG(a-21:0/18:1(12Z)-2OH(9,10)/0:0)

C42H80O7 (696.590373)


   

DG(18:1(12Z)-2OH(9,10)/a-21:0/0:0)

DG(18:1(12Z)-2OH(9,10)/a-21:0/0:0)

C42H80O7 (696.590373)


   

DG(a-21:0/0:0/18:1(12Z)-2OH(9,10))

DG(a-21:0/0:0/18:1(12Z)-2OH(9,10))

C42H80O7 (696.590373)


   

DG(18:1(12Z)-2OH(9,10)/0:0/a-21:0)

DG(18:1(12Z)-2OH(9,10)/0:0/a-21:0)

C42H80O7 (696.590373)


   

DG(i-21:0/18:1(12Z)-2OH(9,10)/0:0)

DG(i-21:0/18:1(12Z)-2OH(9,10)/0:0)

C42H80O7 (696.590373)


   

DG(18:1(12Z)-2OH(9,10)/i-21:0/0:0)

DG(18:1(12Z)-2OH(9,10)/i-21:0/0:0)

C42H80O7 (696.590373)


   

DG(i-21:0/0:0/18:1(12Z)-2OH(9,10))

DG(i-21:0/0:0/18:1(12Z)-2OH(9,10))

C42H80O7 (696.590373)


   

DG(18:1(12Z)-2OH(9,10)/0:0/i-21:0)

DG(18:1(12Z)-2OH(9,10)/0:0/i-21:0)

C42H80O7 (696.590373)


   

DG(21:0/18:1(12Z)-2OH(9,10)/0:0)

DG(21:0/18:1(12Z)-2OH(9,10)/0:0)

C42H80O7 (696.590373)


   

DG(18:1(12Z)-2OH(9,10)/21:0/0:0)

DG(18:1(12Z)-2OH(9,10)/21:0/0:0)

C42H80O7 (696.590373)


   

DG(21:0/0:0/18:1(12Z)-2OH(9,10))

DG(21:0/0:0/18:1(12Z)-2OH(9,10))

C42H80O7 (696.590373)


   

DG(18:1(12Z)-2OH(9,10)/0:0/21:0)

DG(18:1(12Z)-2OH(9,10)/0:0/21:0)

C42H80O7 (696.590373)


   

[10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] (4E,7E,10E,13E,16E,19E)-docosa-4,7,10,13,16,19-hexaenoate

[10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] (4E,7E,10E,13E,16E,19E)-docosa-4,7,10,13,16,19-hexaenoate

C49H76O2 (696.5844996)


   

[17-[(E)-5,6-dimethylhept-3-en-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] (9E,11E,13E,15E,17E)-henicosa-9,11,13,15,17-pentaenoate

[17-[(E)-5,6-dimethylhept-3-en-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] (9E,11E,13E,15E,17E)-henicosa-9,11,13,15,17-pentaenoate

C49H76O2 (696.5844996)


   

[17-[(E)-5-ethyl-6-methylhept-3-en-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] (5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoate

[17-[(E)-5-ethyl-6-methylhept-3-en-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] (5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoate

C49H76O2 (696.5844996)


   

[17-(5-ethyl-6-methylheptan-2-yl)-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] (7E,9E,11Z,13E,15E,17Z)-icosa-7,9,11,13,15,17-hexaenoate

[17-(5-ethyl-6-methylheptan-2-yl)-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] (7E,9E,11Z,13E,15E,17Z)-icosa-7,9,11,13,15,17-hexaenoate

C49H76O2 (696.5844996)


   

[10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate

[10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate

C49H76O2 (696.5844996)


   

4,7,10,13,16,19-Docosahexaenoic acid 3beta-cholesteryl ester

4,7,10,13,16,19-Docosahexaenoic acid 3beta-cholesteryl ester

C49H76O2 (696.5844996)


   

cholesteryl (4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoate

cholesteryl (4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoate

C49H76O2 (696.5844996)


A cholesterol ester in which the acyl group is specified as (4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl.

   

ChE(22:6)

ChE(22:6)

C49H76O2 (696.5844996)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

ZyE(22:5)

ZyE(22:5)

C49H76O2 (696.5844996)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

Sitosterol Ester 22:6

Sitosterol Ester 22:6

C49H76O2 (696.5844996)


   

octatriacontyl 2,2,3,3,3-pentafluoropropanoate

octatriacontyl 2,2,3,3,3-pentafluoropropanoate

C41H77F5O2 (696.5843402)